A new general glucose homeostatic model using a proportional-integral-derivative controller

Computer Methods and Programs in Biomedicine

Volumn 102, Issue 2, 2011, Pages 119-129

  Watson, E M ^a,b   Chappell, M J ^b   Ducrozet, F ^a,c   Poucher, S M ^a   Yates, J W T ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Harlan   (Switzerland)

Author keywords

Diabetes; Glucose; Insulin; Mathematical models; PID control; Structural identifiability

Indexed keywords

DIABETES; ENGINEERING CONTROL PROBLEMS; FEEDBACK MECHANISMS; GLUCOSE PRODUCTION; HOMEOSTATIC MECHANISM; HOMEOSTATIC MODEL; INSULIN ACTION; INSULIN SECRETION; INTEGRAL FUNCTION; INTRAVENOUS GLUCOSE TOLERANCE TEST; MODEL BASED APPROACH; MODEL SIMULATION; NEW APPROACHES; PARAMETER VALUES; PID CONTROL; PROPORTIONAL CONTROL; PROPORTIONAL INTEGRAL DERIVATIVE CONTROLLERS; PROPORTIONAL-INTEGRAL-DERIVATIVE TYPE CONTROLLERS; RESEARCH AREAS; STRUCTURAL IDENTIFIABILITY; THREE PHASIS; TRACER EXPERIMENT; TWO PARAMETER;

COMPUTER SIMULATION; CONTROLLERS; GLUCOSE; INSULIN; MATHEMATICAL MODELS; MEDICAL PROBLEMS; PARAMETER ESTIMATION; THREE TERM CONTROL SYSTEMS; TWO TERM CONTROL SYSTEMS;

PROPORTIONAL CONTROL SYSTEMS;

GLUCOSE; INSULIN;

ARTICLE; BIOENGINEERING; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MATHEMATICAL MODEL; NONHUMAN; PROPORTIONAL INTEGRAL DERIVATIVE CONTROLLER; SIMULATION;

ANIMALS; BIOMEDICAL ENGINEERING; BLOOD GLUCOSE; COMPUTER SIMULATION; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; RATS;

EID: 79955132161     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmpb.2010.08.013     Document Type: Article

References (34)

1. Bergman R., Ider Y., Bowden C., Cobelli C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 1979, 236(6):E667-E677.
2. De Gaetano A., Arino O. Mathematical modelling of the intravenous glucose tolerance test. J. Math. Biol. 2000, 40(2):136-168.
3. Topp B., Promislow K., deVries G., Miura R., Finegood D. A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. J. Theor. Biol. 2000, 206(4):605-619.
4. Silber H.E., Jauslin P.M., Frey N., Gieschke R., Simonsson U.S., Karlsson M.O. An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations. J. Clin. Pharmacol. 2007, 47(9):1159-1171.
5. Haffner S. Type 2 Diabetes: Unravelling its Causes and Consequences: A Compendium of Classical Papers 2002, Medical Publications, Cambridge.
6. Bolie V.W. Coefficients of normal blood glucose regulation. J. Appl. Physiol. 1961, 16(5):783-788.
7. Kasiske B., O'Donnell M., Keane W. The zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992, 19(1 Suppl.):I110-I115.
8. Vester M., Van der Linden R., Pangels J. Control design for an industrial distillation column. Comput. Chem. Eng. 1993, 17(5-6):609-615.
9. Bissell C. Control Engineering 1994, CRC Press. Vol. 2nd Revised edition.
10. Steil G.M., Panteleon A.E., Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv. Drug Deliv. Rev. 2004, 56:125-144.
11. Steil G.M., Clark B., Kanderian S., Rebrin K. Modeling insulin action for development of a closed-loop artificial pancreas. Diabetes Technol. Ther. 2005, 7:94-108.
12. Doran C.V., Hudson N.H., Moorhead K.T., Chase J.G., Shaw G.M., Hann C.E. Derivative weighted active insulin control modelling and clinical trials for ICU patients. Med. Eng. Phys. 2005, 26:94-108.
13. Marchetti G., Barolo M., Jovanic L., Zisser H., Seborg D.E. An improved PID switching control strategy for type 1 diabetes. IEEE Trans. Biomed. Eng. 2004, 55:857-865.
14. Wintergerst K.A., Deiss D., Buckingham B., Cantwell M., Kache S., Agarwal S., Wilson D.M., Steil G. Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. Diabetes Technol. Ther. 2008, 9:211-222.
15. Steil G., Rebrin K., Mastrototaro J.J. Metabolic modelling and the closed-loop insulin delivery problem. Diabetes Res. Clin. Pract. 2006, 74(Suppl. 2):S183-S186.
16. Langin D. Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion. N. Engl. J. Med. 2001, 345(24):1772-1774.
17. Bratanova-Tochkova T., Cheng H., Daniel S., Gunawardana S., Liu Y., Mulvaney-Musa J., Schermerhorn T., Straub S., Yajima H., Sharp G. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 2002, 51(Suppl. 1):S83-S90.
18. Carson E.R., Cobelli C. Modelling Methodology for Physiology and Medicine 2001, Academic, San Diego, Calif.
19. Natali A., Gastaldelli A., Camastra S., Sironi A.M., Toschi E., Masoni A., Ferrannini E., Mari A. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am. J. Physiol. Endocrinol. Metab. 2000, 278:794-801.
20. Prigeon R.L., Roder M.E., Porte D., Kahn S.E. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J. Clin. Invest. 1996, 97:501-507.
21. Muller M., Paschen U., Seitz H. Glucose production measured by tracer and balance data in conscious miniature pig. Am. J. Physiol. Endocrinol. Metab. 1983, 244(3):E236-E244.
22. Lima J.J., Matsushima N., Kissoon N., Wang J., Sylvester J.E., Jusko W.J. Modeling the metabolic effects of terbutaline in [beta]2-adrenergic receptor diplotypes[ast]. Clin. Pharmacol. Ther. 2004, 76(1):27-37.
23. Chappell M.J., Godfrey K., Vajda S. Global identifiability of the parameters of nonlinear systems with specified inputs: a comparison of methods. Math. Biosci. 1990, 102(1):41-73.
24. Yates J.W., Evans N.D., Chappell M.J. Structural identifiability analysis via symmetries of differential equations. Automatica 2009, 45(11):2585-2591. doi:10.1016/j.automatica.2009.07.009.
25. Wolfram, Mathematica (2009). http://www.wolfram.com/.
26. Pacini G., Bergman R. Minmod: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 1986, 23(2):113-122.
27. AEgis, acslx (2008). http://www.acslx.com/.
28. Docherty P., Chase J., Lotz T., Hann C., Shaw G., Berkeley J., Mann J., McAuley K. DISTq: an iterative analysis of glucose data for low-cost, real-time and accurate estimation of insulin sensitivity. Open Med. Inform. J. 2009, 3:65-76.
29. Lotz T.F., Chase J.G., McAuley K.A., Shaw G.M., Wong X.W., Lin J., Lecompte A., Hann C.E., Mann J.I. Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput. Methods Programs Biomed. 2008, 89:215-225.
30. Mari A., Valerio A. A circulatory model for the estimation of insulin sensitivity. Control Eng. Pract. 1997, 5:1747-1752.
31. Watanabe R., Bergman R. Accurate measurement of endogenous insulin secretion does not require separate assessment of c-peptide kinetics. Diabetes 2000, 49(3):373-382.
32. O'Connor M., Landahl H., Grodsky G. Comparison of storage- and signal-limited models of pancreatic insulin secretion. Am. J. Physiol. 1980, 238(5):R378-R389.
33. Kaufman F.R., Gibson L.C., Halvorson M., Carpenter S., Fisher L.K., Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001, 24(12):2030-2034.
34. Ibbini M. A PI-fuzzy logic controller for the regulation of blood glucose level in diabetic patients. J. Med. Eng. Technol. 2006, 30:83-92.